Eyal Waldman and Dr. Martin Rosenzweig Join CalmiGo’s Advisory Board

CalmiGo Welcomes Renowned Leaders

CalmiGo, developer of the only mental health platform that delivers both immediate relief and long-term care for individuals facing anxiety, PTSD, and panic attacks, has announced the appointment of two highly respected leaders to its advisory board: Eyal Waldman, co-founder of Mellanox Technologies, and Dr. Martin Rosenzweig, a leading behavioral health expert and former executive at UnitedHealth Group.

This strategic addition strengthens CalmiGo’s mission to redefine how mental health is supported worldwide, by offering clinically proven, accessible, and cost-effective solutions.

A Global Technology Visionary Joins

Eyal Waldman, an internationally recognized entrepreneur and philanthropist, is best known for co-founding Mellanox Technologies and leading it to a $6.9 billion acquisition by NVIDIA in 2019. Today, he serves as Chairman of Waldo Holdings, where he continues to support and scale innovative ventures across industries.

“CalmiGo is uniquely positioned to scale rapidly and transform the healthcare landscape. Its proven ability to deliver immediate relief for those facing anxiety and PTSD in just three minutes of use makes it a breakthrough technology with vast growth potential,” said Waldman. “I am thrilled to join forces with a team of experts who are leading a technological revolution in the mental healthcare space.”

A Behavioral Health Pioneer Lends His Expertise

Dr. Martin Rosenzweig brings more than 25 years of experience in behavioral health and managed care. As former Behavioral Chief Medical Officer at Optum (a UnitedHealth Group company), he spearheaded initiatives that expanded access to psychiatric care and addressed urgent challenges such as the opioid crisis.

“I am excited to join the advisory board of a company that offers a cost-effective, clinically proven approach to supporting individuals affected by anxiety and trauma, without requiring a prescription,” said Rosenzweig. “The CalmiGo platform not only empowers individuals but also provides clinicians and organizations with valuable behavioral and physiological insights.”

Strengthening CalmiGo’s Path Forward

CalmiGo’s CEO, Adi Wallach, highlighted the significance of these appointments:
“We are honored to add these two prestigious leaders in healthcare and technology to our advisory board. Their expertise will guide our growth as we continue to create innovative solutions that improve the mental health of users worldwide.”

With its growing advisory board of thought leaders, CalmiGo is positioned to scale its impact globally, empowering millions of individuals and organizations with better tools for mental health care.

Check the article on Geektime (Hebrew).